TG Therapeutics Investigational Trial Site

Rochester, New York 14642

1 studies enrolling now · 3 studies all time

What they study most

B-cell Mediated Autoimmune Disorders, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma

Studies at this site

• A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders — Recruiting now
• Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy — Stopped early
• Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL — Stopped early